Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anaemia Due to Angiodysplasias
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether long-acting octreotide is effective in the
treatment of patients with refractory anaemia due to angiodysplasias.
The hypothesis is that long-acting octreotide is effective in decreasing the blood and iron
infusion requirements in those patients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Radboud University
Collaborators:
Bernhoven Bernhoven Hospital Catharina Ziekenhuis Eindhoven Elisabeth-TweeSteden Ziekenhuis Gelre Hospitals Jeroen Bosch Ziekenhuis Reinier de Graaf Groep St. Antonius Hospital VU University Medical Center